Andrew Green
Endocrinology, Diabetes & Metabolism · Shawnee Mission, KSNPI 1255325791
Payments from drug & device makers
$322,471in general payments, 2019–2025
Across 885 payments — averaging $364.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$199K
- Boehringer Ingelheim$53K
- Lilly USA, LLC$43K
- AbbVie$12K
- Johnson & Johnson$7K
- Mannkind Corporation$5K
- plus $4K from 33 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 342 | $198,550 |
| Boehringer Ingelheim | 95 | $53,084 |
| Lilly USA, LLC | 131 | $42,689 |
| AbbVie | 43 | $11,582 |
| Johnson & Johnson | 10 | $7,161 |
| Mannkind Corporation | 11 | $5,050 |
| Abbott | 39 | $576 |
| AstraZeneca(2 entities) | 28 | $458 |
| Pfizer | 21 | $341 |
| Sanofi-aventis U.S. LLC | 21 | $301 |
| Merck | 19 | $289 |
| Bayer | 10 | $274 |
| Insulet Corporation | 11 | $259 |
| Corcept Therapeutics | 13 | $256 |
| Amgen(2 entities) | 14 | $224 |
| Radius Health, Inc. | 9 | $222 |
| Ascensia Diabetes Care US Inc. | 11 | $207 |
| Amarin Pharma, Inc. | 14 | $202 |
| Amneal Pharmaceuticals LLC | 10 | $151 |
| Dexcom, Inc. | 5 | $136 |
| Tandem Diabetes Care, Inc. | 4 | $75 |
| Medtronic(2 entities) | 4 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Clarus Therapeutics Inc. | 2 | $25 |
| Cequr Corporation | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $17 |
| Companion Medical, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| Aegerion Pharmaceuticals, Inc. | 1 | $15 |
| Zealand Pharma US, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Vivus LLC | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Nevro Corp. | 1 | $13 |
How this compares
$322,471 in reported general payments places this provider in the 90th percentile of 50 endocrinology, diabetes & metabolism providers in Kansas.
See all endocrinology, diabetes & metabolism providers in Kansas →
Other endocrinology, diabetes & metabolism in Shawnee Mission
- John LiuShawnee Mission$8K
- Alan WynneTopeka$6.9M
- Susan BrianTopeka$2.8M
- Dany ZayourWichita$744K
- Michael SokolOverland Park$227K
- Rami MortadaWichita$105K
- Kristine GrdinovacKansas City$82K
- Sajeev MenonOverland Park$26K
- Leland GravesKansas City$23K
- Rudruidee KarnchanasornKansas City$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.